EUVIMEDEUVIMED entdecken
Multizentrische Studie

Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement

Antonin Trimaille iD, Pedro Cepas-Guillén iD, Marina Urena iD, Alberto Alperi iD, Gabriela Veiga-Fernandez iD, Luis Nombela-Franco iD, Victoria Vilalta iD, Maria Del Trigo iD, Antonio J Muñoz-García, Giovanni Esposito iD, Vincent Auffret iD, David Del Val iD und 21 weitere

Circulation: Cardiovascular Interventions · 2026

DOI: 10.1161/circinterventions.126.016892 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2026. Verfasst von Antonin Trimaille und 32 weiteren Autor:innen. Beteiligte Einrichtung: Quebec Heart & Lung Institute, Laval University, Canada (A.T., P.C.-G., M.A., J.R.-C.). Hauptthemen laut MEDLINE: Bioprosthesis, Heart Valve Prosthesis, Prosthesis Failure, Aortic Valve. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Data on the long-term incidence and clinical impact of bioprosthetic valve failure (BVF) after transcatheter aortic valve replacement remain limited. This study aimed to assess the incidence, predictors, and clinical impact of BVF following transcatheter aortic valve replacement. METHODS: We analyzed data from an international, multicenter registry including consecutive patients undergoing transcatheter aortic valve replacement at 13 centers. The primary outcome was BVF according to Valve Academic Research Consortium-3 criteria. The cumulative incidence of BVF was estimated using a competing-risk approach. The association between BVF and clinical outcomes was assessed using competing-risk models with BVF as a time-dependent covariate. RESULTS: Among 7501 patients, BVF occurred in 380 (5.1%) patients over a median follow-up of 4 (interquartile range, 2–5) years. The cumulative incidence of BVF increased over time, reaching 1.4% at 1 year, 4.6% at 5 years, and 8.3% at 10 years. Independent predictors of BVF included younger age, smoking, balloon-expandable valve, prosthesis size

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BioprosthesisHeart Valve ProsthesisProsthesis FailureAortic ValveTranscatheter Aortic Valve ReplacementAortic Valve StenosisAortic Valve InsufficiencyHumansRisk FactorsProsthesis DesignTime FactorsRegistriesAged, 80 and overFemaleIncidenceRisk AssessmentMaleAgedHemodynamicsTreatment Outcome

Stichwörter der Autor:innen

aortic valveaortic valve stenosisbioprosthesisheart valve prosthesisprosthesis failuretranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Quebec Heart & Lung Institute, Laval University, Canada (A.T., P.C.-G., M.A., J.R.-C.).
  • Department of Cardiovascular Medicine, Nouvel Hôpital Civil Strasbourg University Hospital, France (A.T., A.C., O.M.).
  • Cardiology Department, Institut Clínic Cardiovascular, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain (P.C.-G., A.R., E.F.-U., J.R-C.).
  • Cardiology Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, France (M.U., Q.F.).
  • Área del Corazón. Hospital Universitario Central de Asturias, Oviedo, Spain (A.A., P.A.).
  • Instituto de Investigación Sanitaria del Principado de Asturias, ISPA, Oviedo, Spain (A.A., P.A.).

ORCID-Profile: Antonin Trimaille, Pedro Cepas-Guillén, Marina Urena, Alberto Alperi, Gabriela Veiga-Fernandez, Luis Nombela-Franco, Victoria Vilalta, Maria Del Trigo, Giovanni Esposito, Vincent Auffret, David Del Val, Jorge Nuche, Lluis Asmarats, Adrien Carmona, Quentin Fisher, Pablo Avanzas, Víctor Fradejas-Sastre, Ivan Sanchez, Juan Francisco Oteo, Anna Franzone, Fernando Alfonso, Rocío Rodríguez-Santolino, Dabit Arzamendi, Eduardo Flores-Umanzor, Olivier Morel, Marisa Avvedimento, Josep Rodés-Cabau

Zitieren

APA

Trimaille, A., Cepas-Guillén, P., Urena, M., Alperi, A., Veiga-Fernandez, G., Nombela-Franco, L., Vilalta, V., Del Trigo, M., Muñoz-García, A. J., Esposito, G., Auffret, V., Del Val, D., Serra, V., Nuche, J., Asmarats, L., Regueiro, A., Carmona, A., Fisher, Q., Avanzas, P., …, & Rodés-Cabau, J. (2026). Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.126.016892

Vancouver

Trimaille A, Cepas-Guillén P, Urena M, Alperi A, Veiga-Fernandez G, Nombela-Franco L, et al. Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement. Circulation: Cardiovascular Interventions. 2026. doi:10.1161/circinterventions.126.016892

BibTeX
@article{Trimaille2026,
  author = {Trimaille, Antonin and Cepas-Guillén, Pedro and Urena, Marina and Alperi, Alberto and Veiga-Fernandez, Gabriela and Nombela-Franco, Luis and Vilalta, Victoria and Del Trigo, Maria and Muñoz-García, Antonio J and Esposito, Giovanni and Auffret, Vincent and Del Val, David and Serra, Vicenç and Nuche, Jorge and Asmarats, Lluis and Regueiro, Ander and Carmona, Adrien and Fisher, Quentin and Avanzas, Pablo and Fradejas-Sastre, Víctor and Sanchez, Ivan and Trichilo, Michele and Francisco Oteo, Juan and Franzone, Anna and Nolf, Maxime and Alfonso, Fernando and Díaz Pockels, Pedro and Rodríguez-Santolino, Rocío and Arzamendi, Dabit and Flores-Umanzor, Eduardo and Morel, Olivier and Avvedimento, Marisa and Rodés-Cabau, Josep},
  title = {Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2026},
  doi = {10.1161/circinterventions.126.016892}
}
Kostenlos starten →